Leniolisib, a medication used to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome, carries a significant cost. The price of leniolisib can vary, but it is generally considered expensive.
What is the typical price for Leniolisib?
While specific list prices can fluctuate, leniolisib is often cited with a monthly cost in the tens of thousands of dollars. For example, some sources indicate a list price in the range of $20,000 to $30,000 per month [1]. This high cost is not uncommon for specialty medications treating rare diseases.
How can patients afford Leniolisib?
Given the substantial cost, many patients rely on financial assistance programs to manage their leniolisib expenses. Manufacturers often provide patient support services that may include co-pay assistance or access to foundation grants. Insurance coverage plays a crucial role, and patients may need to navigate prior authorization processes. Detailed information on available financial aid can typically be found through the drug's official website or patient support hotlines.
What is PI3Kδ syndrome and why is Leniolisib used for it?
Activated PI3Kδ syndrome (APDS) is a rare, primary immunodeficiency disease characterized by a combination of immune dysregulation and severe lymphoproliferation. It results from genetic mutations that lead to overactive PI3Kδ, an enzyme crucial for immune cell function. Leniolisib is a targeted therapy that inhibits the PI3Kδ enzyme, aiming to restore normal immune cell signaling and reduce disease symptoms [1].
When might Leniolisib become more affordable?
The cost of medications can decrease with the introduction of generic alternatives. However, for leniolisib, generic competition is not currently a factor. The patent protection for drugs like leniolisib typically lasts for a significant period, preventing the entry of lower-cost generic versions. Information on the patent landscape for leniolisib can be accessed through resources like DrugPatentWatch.com [2].
What are the potential side effects of Leniolisib?
Common side effects reported with leniolisib include edema, nausea, diarrhea, fever, and respiratory tract infections [1]. Patients are advised to discuss all potential risks and side effects with their healthcare provider.
Sources:
[1] https://www.drugpatentwatch.com/p/leniosi-874053
[2] https://www.drugpatentwatch.com/